Results 281 to 290 of about 4,676,099 (307)
Some of the next articles are maybe not open access.
Immunosuppressive therapy for ocular diseases
Current Opinion in Ophthalmology, 2008To identify advances in immunosuppressive therapy of ocular diseases since 2007.The biologics in current use include antitumour necrosis factor-alpha agents (infliximab, etanercept and adalimumab), cytokine receptor antibodies (daclizumab) and interferon-alpha2a. They are effective and comparatively well tolerated options in the treatment of refractory
Aliza Jap, Soon-Phaik Chee
openaire +3 more sources
Transplantation and immunosuppressive therapy
Anaesthesia & Intensive Care Medicine, 2006Abstract Anaesthetist and intensive care physicians will probably be involved, at some stage, in the care of patients who have had or are undergoing organ transplantation. This requires an understanding of the immune response and the drugs used to facilitate transplantation.
David B. Kingsmore, Catherine J Wallace
openaire +2 more sources
Immunosuppressant therapy during gestation
Seminars in Perinatology, 1997Use of immunosuppressants during pregnancy is indicated for anti-rejection therapy in transplantation patients and treatment of autoimmune diseases. Maternal side effects include nephrotoxocity and hepatotoxicity. All immunosuppressant drugs cross the placenta.
openaire +3 more sources
Overview of new immunosuppressive therapies
Current Opinion in Pediatrics, 2000This review covers the new immunosuppressive drugs that have appeared in the past 5 years. It begins with the newest formulation (Neoral, Sandoz Pharmaceuticals, East Hanover, NJ, USA) of the clinically "mature" drug cyclosporin A and then reviews the literature on tacrolimus, sirolimus, and mycophenolate mofetil.
openaire +3 more sources
1985
Publisher Summary Immunological tissue damage is a common cause of acute and chronic disease in man. Immune reactions also hinder transplantation of bone marrow or solid organs between histoincompatible individuals. As immunological disease and transplantation reactions often result in severe, occasionally life-threatening conditions, it is important ...
openaire +2 more sources
Publisher Summary Immunological tissue damage is a common cause of acute and chronic disease in man. Immune reactions also hinder transplantation of bone marrow or solid organs between histoincompatible individuals. As immunological disease and transplantation reactions often result in severe, occasionally life-threatening conditions, it is important ...
openaire +2 more sources
Pregnancy and Immunosuppressive Drug Therapy
The Journal of Perinatal & Neonatal Nursing, 1996Pregnancies in women who have previously received an organ transplant are becoming more common. This is evidenced by the growing number of case reports and published studies of pregnancy outcomes involving transplant recipients. Perinatal nurses must expand their knowledge base to provide comprehensive care to this growing population.
openaire +3 more sources
Immunosuppression in uveitis therapy
Springer Seminars in Immunopathology, 1999R.N. Van Gelder, Henry J. Kaplan
openaire +3 more sources
Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?
Nature reviews: Gastroenterology & hepatology, 2022E. Villablanca, K. Selin, C. Hedin
semanticscholar +1 more source
Preparing the Patient for Immunosuppressive Therapy
Current Gastroenterology Reports, 2010The decision to start immunosuppressive therapy comes with benefits and risks. Patient selection is as important as medication selection, because some patients are not appropriate for certain therapies. The decision is based on many factors, including diagnosis, level of disease activity, comorbidities, and sometimes socioeconomic status.
openaire +3 more sources
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
Nature Reviews Clinical Oncology, 2019Y. Togashi, K. Shitara, H. Nishikawa
semanticscholar +1 more source